Publicaciones científicas
-
Reyes, R, Moreno-Perez, O, Tejera-Perez, C, Brito-Sanfiel, M, Pines, P, Aguilera, E, Gargallo, M, Rozas-Moreno, P and Martin, JES.
Glucometrics knowledge and its relationship to glycemic control in people living with type 1 diabetes: The GluKometrics study
DIABETES & METABOLISM 50(1):
-
Perna-Barrull, D, Gomez-Munoz, L, Rodriguez-Fernandez, S, Gieras, A, Ampudia-Carrasco, RM, Almenara-Fuentes, L, Risueno, RM, Querol, S, Tolosa, E and Vives-Pi, M.
Impact of Betamethasone Pretreatment on Engrafment of Cord Blood-Derived Hematopoietic Stem Cells
Archivum Immunologiae et Therapiae Experimentalis 71(1):
-
Gomez-Munoz, Laia, Dominguez-Bendala, Juan, Pastori, Ricardo L and Vives-Pi, Marta.
Immunometabolic biomarkers for partial remission in type 1 diabetes mellitus.
TRENDS IN ENDOCRINOLOGY AND METABOLISM 35(2): 151-163
-
Bellido, V, Aguilera, E, Cardona-Hernandez, R, Diaz-Soto, G, de Villar, NGP, Picón-César, MJ and Ampudia-Blasco, FJ.
Expert Recommendations for Using Time-in-Range and Other Continuous Glucose Monitoring Metrics to Achieve Patient-Centered Glycemic Control in People With Diabetes
Journal of diabetes science and technology 17(5): 1326-1336
-
Corral-Pujol, M, Arpa, B, Rosell-Mases, E, Egia-Mendikute, L, Mora, C, Stratmann, T, Sanchez, A, Casanovas, A, Esquerda, JE, Mauricio, D, Vives-Pi, M and Verdaguer, J.
NOD mouse dorsal root ganglia display morphological and gene expression defects before and during autoimmune diabetes development
Frontiers in Endocrinology 14:
-
Gomez-Munoz, L, Perna-Barrull, D, Murillo, M, Armengol, MP, Alcalde, M, Catala, M, Rodriguez-Fernandez, S, Sunye, S, Valls, A, Perez, J, Corripio, R and Vives-Pi, M.
Immunoregulatory Biomarkers of the Remission Phase in Type 1 Diabetes: miR-30d-5p Modulates PD-1 Expression and Regulatory T Cell Expansion
Non-coding RNA 9(2):
-
Salvia, R, Rico, LG, Bradford, JA, Ward, MD, Olszowy, MW, Martinez, C, Madrid-Aris, AD, Grifols, JR, Ancochea, A, Gomez-Munoz, L, Vives-Pi, M, Martinez-Caceres, E, Fernandez, MA, Sorigue, M and Petriz, J.
Fast-screening flow cytometry method for detecting nanoplastics in human peripheral blood
MethodsX 10:
-
Almenara-Fuentes, L, Rodriguez-Fernandez, S, Rosell-Mases, E, Kachler, K, You, AX, Salvado, M, Andreev, D, Steffen, U, Bang, H, Bozec, A, Schett, G, Le Panse, R, Verdaguer, J, Dalmases, M, Rodriguez-Vidal, S, Barneda-Zahonero, B and Vives-Pi, M.
A new platform for autoimmune diseases. Inducing tolerance with liposomes encapsulating autoantigens
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE 48:
-
Perna-Barrull, D, Murillo, M, Real, N, Gomez-Munoz, L, Rodriguez-Fernandez, S, Bel, J, Puig-Domingo, M and Vives-Pi, M.
Prenatal Betamethasone Exposure and its Impact on Pediatric Type 1 Diabetes Mellitus: A Preliminary Study in a Spanish Cohort
Journal of Diabetes Research 2022:
-
Gomez-Munoz, L, Perna-Barrull, D, Caroz-Armayones, JM, Murillo, M, Rodriguez-Fernandez, S, Valls, A, Vazquez, F, Perez, J, Corripio, R, Castano, L, Bel, J and Vives-Pi, M.
Candidate Biomarkers for the Prediction and Monitoring of Partial Remission in Pediatric Type 1 Diabetes
Frontiers in Immunology 13:
-
Teniente-Serra, A, Pizarro, E, Quirant-Sanchez, B, Fernandez, MA, Vives-Pi, M and Martinez-Caceres, EM.
Identifying Changes in Peripheral Lymphocyte Subpopulations in Adult Onset Type 1 Diabetes
Frontiers in Immunology 12: 784110-784110
-
Rodriguez-Fernandez, S, Almenara-Fuentes, L, Perna-Barrull, D, Barneda, B and Vives-Pi, M.
A century later, still fighting back: antigen-specific immunotherapies for type 1 diabetes
Immunology and Cell Biology 99(5): 461-474
-
Gomez-Munoz, L, Perna-Barrull, D, Villalba, A, Rodriguez-Fernandez, S, Ampudia, RM, Teniente-Serra, A, Vazquez, F, Murillo, M, Perez, J, Corripio, R, Bel, J and Vives-Pi, M.
NK Cell Subsets Changes in Partial Remission and Early Stages of Pediatric Type 1 Diabetes
Frontiers in Immunology 11: 611522-611522
-
Villalba A, Rodriguez-Fernandez S, Ampudia RM, Cano-Sarabia M, Perna-Barrull D, Bertran-Cobo C, Ehrenberg C, Maspoch D and Vives-Pi M.
Preclinical evaluation of antigen-specific nanotherapy based on phosphatidylserine-liposomes for type 1 diabetes.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY 48(1): 77-83
-
Villalba, A, Rodriguez-Fernandez, S, Perna-Barrull, D, Ampudia, RM, Gomez-Munoz, L, Pujol-Autonell, I, Aguilera, E, Risueno, RM, Cano-Sarabia, M, Maspoch, D, Vazquez, F and Vives-Pi, M.
Antigen-specific immunotherapy combined with a regenerative drug in the treatment of experimental type 1 diabetes
Scientific Reports 10(1): 18927-18927
-
Perna-Barrull, D, Gieras, A, Rodriguez-Fernandez, S, Tolosa, E and Vives-Pi, M.
Immune System Remodelling by Prenatal Betamethasone: Effects on beta-Cells and Type 1 Diabetes
Frontiers in Endocrinology 11: 540-540
-
Villalba, A, Rodriguez-Fernandez, S, Perna-Barrull, D, Ampudia, RM, Gomez-Munoz, L, Pujol-Autonell, I, Aguilera, E, Coma, M, Cano-Sarabia, M, Vazquez, F, Verdaguer, J and Vives-Pi, M.
Repurposed Analog of GLP-1 Ameliorates Hyperglycemia in Type 1 Diabetic Mice Through Pancreatic Cell Reprogramming
Frontiers in Endocrinology 11: 258-258
-
Piquer-Garcia, I, Campderros, L, Taxeras, SD, Gavalda-Navarro, A, Pardo, R, Vila, M, Pellitero, S, Martinez, E, Tarasco, J, Moreno, P, Villarroya, J, Cereijo, R, Gonzalez, L, Reyes, M, Rodriguez-Fernandez, S, Vives-Pi, M, Lerin, C, Elks, CM, Stephens, JM, Puig-Domingo, M, Villarroya, F, Villena, JA and Sanchez-Infantes, D.
A Role for Oncostatin M in the Impairment of Glucose Homeostasis in Obesity
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM 105(3): 337-348
-
Chico A, Aguilera E, Ampudia-Blasco FJ, Bellido V, Cardona-Hernández R, Escalada FJ, Fernández D, Gómez-Peralta F, González Pérez de Villar N, Gorgojo JJ, Mezquita-Raya P, Morales C, de Pablos Velasco P, Palomares R, Parra J, Rivero MT and González-Blanco C.
Clinical Approach to Flash Glucose Monitoring: An Expert Recommendation.
Journal of diabetes science and technology 14(1): 155-164
-
Rodriguez-Fernandez, S, Murillo, M, Villalba, A, Perna-Barrull, D, Cano-Sarabia, M, Gomez-Munoz, L, Aguilera, E, Maspoch, D, Vazquez, F, Bel, J and Vives-Pi, M.
Impaired Phagocytosis in Dendritic Cells From Pediatric Patients With Type 1 Diabetes Does Not Hamper Their Tolerogenic Potential
Frontiers in Immunology 10: 2811-2811
-
Villalba, A, Fonolleda, M, Murillo, M, Rodriguez-Fernandez, S, Ampudia, RM, Perna-Barrull, D, Raina, MB, Quirant-Sanchez, B, Planas, R, Teniente-Serra, A, Bel, J and Vives-Pi, M.
Partial remission and early stages of pediatric type 1 diabetes display immunoregulatory changes. A pilot study
Translational Research 210: 8-25
-
Egia-Mendikute, L, Arpa, B, Rosell-Mases, E, Corral-Pujol, M, Carrascal, J, Carrillo, J, Mora, C, Chapman, H, Panosa, A, Vives-Pi, M, Stratmann, T, Serreze, D and Verdaguer, J.
B-Lymphocyte Phenotype Determines T-Lymphocyte Subset Differentiation in Autoimmune Diabetes
Frontiers in Immunology 10: 1732-1732
-
Deiss, D, Szadkowska, A, Gordon, D, Mallipedhi, A, Schutz-Fuhrmann, I, Aguilera, E, Ringsell, C, De Block, C and Irace, C.
Clinical Practice Recommendations on the Routine Use of Eversense, the First Long-Term Implantable Continuous Glucose Monitoring System
DIABETES TECHNOLOGY & THERAPEUTICS 21(5): 254-264
-
Perna-Barrull, D, Rodriguez-Fernandez, S, Pujol-Autonell, I, Gieras, A, Ampudia-Carrasco, RM, Villalba, A, Glau, L, Tolosa, E and Vives-Pi, M.
Prenatal Betamethasone interferes with immune system development and alters target cells in autoimmune diabetes
Scientific Reports 9(1): 1235-1235